Ledger.Open graph →
SEC Form D · filed June 1, 2018

Vergent Bioscience, Inc

Offering
$8.7M
Sold
$8.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MINNEAPOLIS, MN
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Samuel D. Banks · MINNEAPOLIS, MNDirectorJeffrey Julkowski · MINNEAPOLIS, MNDirector · PromoterJeffrey D. Yurecko · MINNEAPOLIS, MNExecJohn Santini · Chanhassen, MNExec · DirectorDouglas D. Kohrs · MINNEAPOLIS, MNDirectorRaymond D. Wong · MINNEAPOLIS, MNDirectorSamuel D. Banks · MINNEAPOLIS, MNDirectorJeffrey Julkowski · MINNEAPOLIS, MNDirector · PromoterJeffrey D. Yurecko · MINNEAPOLIS, MNExecJohn Santini · Bedford, MAExec · DirectorDouglas D. Kohrs · MINNEAPOLIS, MNDirectorRaymond D. Wong · MINNEAPOLIS, MNDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗